Randomized Comparison of Everolimus-Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery Disease in Patients With Diabetes Mellitus (ESSENCE-DIABETES)
Author(s) -
WonJang Kim,
SeungWhan Lee,
SeongWook Park,
YoungHak Kim,
SungCheol Yun,
JongYoung Lee,
DukWoo Park,
SooJin Kang,
Cheol Whan Lee,
JaeHwan Lee,
Si Wan Choi,
In Whan Seong,
BongKi Lee,
NaeHee Lee,
Yoon Haeng Cho,
WonYong Shin,
SeungJin Lee,
Se-Whan Lee,
MinSu Hyon,
Duk-Won Bang,
Woo Jung Park,
HyunSook Kim,
Jei Keon Chae,
Keun Lee,
Hoon-Ki Park,
Chang-Bum Park,
Sang-Gon Lee,
Min Kyu Kim,
KyoungHa Park,
YoungJin Choi,
SangSig Cheong,
TaeHyun Yang,
JaeSik Jang,
SungHo Her,
SeungJung Park
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.110.015453
Subject(s) - medicine , sirolimus , diabetes mellitus , coronary artery disease , stent , cardiology , everolimus , drug eluting stent , restenosis , endocrinology
Drug-eluting stents significantly improved angiographic and clinical outcomes compared with bare metal stents in diabetic patients. However, a comparison of everolimus-eluting stents and sirolimus-eluting stents in diabetic patients has not been evaluated. Therefore we compared effectiveness of everolimus-eluting stents and sirolimus-eluting stents in patients with diabetes mellitus.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom